Zynex, Inc. (ZYXI)

Market Cap	67.74M
Revenue (ttm)	172.40M
Net Income (ttm)	-7.41M
Shares Out	30.24M
EPS (ttm)	-0.24
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	106,163
Open	2.310
Previous Close	2.300
Day's Range	2.200 - 2.310
52-Week Range	1.660 - 10.620
Beta	0.84
Analysts	Buy
Price Target	6.00 (+166.67%)
Earnings Date	Jul 24, 2025

About ZYXI

Zynex, Inc., together with its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain, and activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company offers NexWave, a dual channel, multi-modality interferential current, transcutaneous electrical nerve stimulation, and neuromuscular electrical stimulation (NMES) device that is marketed to physicians and therapists by field sales representatives; NeuroMove, an electromyography and electric stimulation technology de...

• Industry: Medical Distribution
• Sector: Healthcare
• Founded: 1996
• Employees: 1,000
• Stock Exchange: NASDAQ
• Ticker Symbol: ZYXI
• Website: https://www.zynex.com

Financial Performance

In 2024, Zynex's revenue was $192.35 million, an increase of 4.36% compared to the previous year's $184.32 million. Earnings were $2.99 million, a decrease of -69.24%.

Analyst Summary

According to 3 analysts, the average rating for ZYXI stock is "Buy." The 12-month stock price target is $6.0, which is an increase of 166.67% from the latest price.

Price Target

$6.0

(166.67% upside)

Analyst Consensus: Buy